应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NSRX Nasus Pharma Ltd.
休市中 12-05 16:00:00 EST
6.80
-0.05
-0.73%
盘后
6.80
+0.00
0.00%
16:04 EST
最高
6.80
最低
6.80
成交量
1,491
今开
6.80
昨收
6.85
日振幅
0.00%
总市值
6,163万
流通市值
2,708万
总股本
906.35万
成交额
9,973
换手率
0.04%
流通股本
398.27万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Nasus Pharma Ltd.盘中异动 大幅拉升7.14%
市场透视 · 11-22
Nasus Pharma Ltd.盘中异动 大幅拉升7.14%
Nasus Pharma获得加拿大卫生部批准,启动Ns002鼻用肾上腺素粉末的二期临床研究
美股速递 · 11-06
Nasus Pharma获得加拿大卫生部批准,启动Ns002鼻用肾上腺素粉末的二期临床研究
Nasus Pharma宣布扩大协议以支持Ns002鼻内肾上腺素项目的开发和商业化
美股速递 · 10-08
Nasus Pharma宣布扩大协议以支持Ns002鼻内肾上腺素项目的开发和商业化
加载更多
公司概况
公司名称:
Nasus Pharma Ltd.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Nasus Pharma Ltd.是一家以色列公司,于2019年5月在以色列注册成立。他们是一家临床阶段的专业制药公司,主要专注于开发治疗紧急医疗状况的鼻内药物。他们正在开发一种独特的PBI技术,拥有专门的产品组合,以应对急性医疗状况和公共健康威胁。
发行价格:
--
{"stockData":{"symbol":"NSRX","market":"US","secType":"STK","nameCN":"Nasus Pharma Ltd.","latestPrice":6.8,"timestamp":1764968400000,"preClose":6.85,"halted":0,"volume":1491,"hourTrading":{"tag":"盘后","latestPrice":6.8,"preClose":6.8,"latestTime":"16:04 EST","volume":1,"amount":6.8,"timestamp":1764968644413},"delay":0,"floatShares":3982680,"shares":9063458,"eps":-0.217993,"marketStatus":"休市中","change":-0.05,"latestTime":"12-05 16:00:00 EST","open":6.8,"high":6.8,"low":6.8,"amount":9972.529197,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.217993,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"listingDate":1755057600000,"exchange":"NASDAQ","adjPreClose":6.85,"postHourTrading":{"tag":"盘后","latestPrice":6.8,"preClose":6.8,"latestTime":"16:04 EST","volume":1,"amount":6.8,"timestamp":1764968644413},"volumeRatio":1.3709083970042593},"requestUrl":"/m/hq/s/NSRX","defaultTab":"news","newsList":[{"id":"2585171598","title":"Nasus Pharma Ltd.盘中异动 大幅拉升7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585171598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585171598?lang=zh_cn&edition=full","pubTime":"2025-11-22 01:57","pubTimestamp":1763747821,"startTime":"0","endTime":"0","summary":"北京时间2025年11月22日01时57分,Nasus Pharma Ltd.股票出现异动,股价快速上涨7.14%。Nasus Pharma Ltd.股票所在的制药行业中,整体涨幅为1.56%。其相关个股中,Alvotech C/Wts 、Sunshine Biopharma Inc C/Wts 、Scilex Holding Company涨幅较大,Shuttle Pharmaceuticals Holdings, Inc.、Inmed Pharmaceuticals Inc.、Akanda Corp.较为活跃,换手率分别为230.65%、9.95%、8.03%,振幅较大的相关个股有Alvotech C/Wts 、Shuttle Pharmaceuticals Holdings, Inc.、Caring Brands, Inc.,振幅分别为38.81%、27.92%、19.67%。Nasus Pharma Ltd.公司简介:Nasus Pharma Ltd是一家临床阶段的专业制药公司,主要专注于开发用于治疗紧急医疗状况的鼻内药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122015702a4b21ff7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122015702a4b21ff7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NSRX","BK4007"],"gpt_icon":0},{"id":"1150703630","title":"Nasus Pharma获得加拿大卫生部批准,启动Ns002鼻用肾上腺素粉末的二期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1150703630","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150703630?lang=zh_cn&edition=full","pubTime":"2025-11-06 21:03","pubTimestamp":1762434188,"startTime":"0","endTime":"0","summary":"Nasus Pharma获得加拿大卫生部的批准,计划启动Ns002鼻用肾上腺素粉末的二期临床研究。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NSRX","BK4007"],"gpt_icon":0},{"id":"1175095310","title":"Nasus Pharma宣布扩大协议以支持Ns002鼻内肾上腺素项目的开发和商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=1175095310","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175095310?lang=zh_cn&edition=full","pubTime":"2025-10-08 20:06","pubTimestamp":1759925171,"startTime":"0","endTime":"0","summary":"Nasus Pharma宣布扩大协议以支持Ns002鼻内肾上腺素项目的开发和商业化","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NSRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nasuspharma.com","stockEarnings":[{"period":"1week","weight":-0.0286},{"period":"1month","weight":-0.0993},{"period":"3month","weight":-0.1479},{"period":"6month","weight":-0.15},{"period":"ytd","weight":-0.15}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nasus Pharma Ltd.是一家以色列公司,于2019年5月在以色列注册成立。他们是一家临床阶段的专业制药公司,主要专注于开发治疗紧急医疗状况的鼻内药物。他们正在开发一种独特的PBI技术,拥有专门的产品组合,以应对急性医疗状况和公共健康威胁。","exchange":"NASDAQ","name":"Nasus Pharma Ltd.","nameEN":"Nasus Pharma Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nasus Pharma Ltd.(NSRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nasus Pharma Ltd.(NSRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nasus Pharma Ltd.,NSRX,Nasus Pharma Ltd.股票,Nasus Pharma Ltd.股票老虎,Nasus Pharma Ltd.股票老虎国际,Nasus Pharma Ltd.行情,Nasus Pharma Ltd.股票行情,Nasus Pharma Ltd.股价,Nasus Pharma Ltd.股市,Nasus Pharma Ltd.股票价格,Nasus Pharma Ltd.股票交易,Nasus Pharma Ltd.股票购买,Nasus Pharma Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nasus Pharma Ltd.(NSRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nasus Pharma Ltd.(NSRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}